“小体形脆弱新生儿”概念的引入及其重要意义

doi:10.12372/jcp.2025.25e1097

摘要/Abstract

摘要：

2023年5月，《柳叶刀》杂志发表系列专题文章，引入了一个全新的概念——“小体形脆弱新生儿（SVN）”，将早产、小于胎龄（SGA）和低出生体重（LBW）3类新生儿划入同一个范畴下。早产儿、SGA和LBW分别有其各自的定义，长期以来一直作为3类不同人群被纳入不同的临床管理。但是，这三者间存在较多交叉重合，其病理生理机制相互影响，单独定义不能反映这些新生儿的全貌，不仅可能低估高危新生儿的数量，也会对临床处理决策产生影响。SVN概念的提出，旨在通过这一全新视角，加大对SVN的关注，完整反映高危新生儿的总体问题，推动围产医学、新生儿、儿童乃至整个社会的健康与持续发展。未来，SVN势必成为学科发展和临床实践的核心理念。因此，本文从SVN概念引入的背景、对流行病学研究以及预防和干预策略的影响等方面展开综述，以帮助临床医师和医学研究工作者了解这一全新的概念，并理解SVN背后的逻辑和对未来发展的重要意义。

关键词: 小体形脆弱新生儿, 流行病学研究, 预防, 干预策略

Abstract:

In May 2023, a series of thematic articles published in The Lancet introduced a novel concept—small vulnerable neonates (SVN) which categorizes preterm, small for gestational age (SGA), and low birth weight (LBW) neonates under a unified framework. Preterm birth, SGA, and LBW have their respective definitions and have long been considered distinct populations in different clinical practices. However, there is considerable overlap among these three categories, and their pathophysiological mechanisms interact. Isolated definitions fail to capture the full picture of these neonates, potentially leading to an underestimation of the number of high-risk newborns and affecting clinical decision-making. The introduction of the SVN concept aims to increase attention to this group through a new perspective, comprehensively reflect the overall issues of high-risk newborns, and promote the health and sustainable development of perinatal medicine, neonatology, pediatrics, and even society as a whole. In the future, SVN is poised to become a core concept in disciplinary advancement and clinical practice. Therefore, this review elaborates on the background of the SVN concept, its implications for epidemiological research, as well as prevention and intervention strategies, to help clinicians and medical researchers understand this new concept and appreciate the rationale behind SVN and its significance for future development.

Key words: small vulnerable neonate, epidemiological research, prevention, intervention strategy

中图分类号:

陈超. “小体形脆弱新生儿”概念的引入及其重要意义[J]. 临床儿科杂志, 2025, 43(11): 803-806.

CHEN Chao. Significance of introducing the concept of “small vulnerable newborns”[J]. Journal of Clinical Pediatrics, 2025, 43(11): 803-806.

参考文献 24

[1]	Ashorn P, Black RE, Lawn JE, et al. The Lancet Small Vulnerable Newborn Series: science for a healthy start[J]. Lancet, 2020, 396(10253): 743-745. doi: S0140-6736(20)31906-1 pmid: 32919498
[2]	Ashorn P, Ashorn U, Muthiani Y, et al. Small vulnerable newborns-big potential for impact[J]. Lancet, 2023, 401(10389): 1692-1706. doi: 10.1016/S0140-6736(23)00354-9 pmid: 37167991
[3]	Lawn JE, Ohuma EO, Bradley E, et al. Small babies, big risks: global estimates of prevalence and mortality for vulnerable newborns to accelerate change and improve counting[J]. Lancet, 2023, 401(10389): 1707-1719. doi: 10.1016/S0140-6736(23)00522-6 pmid: 37167989
[4]	Hunter PJ, Awoyemi T, Ayede AI, et al. Biological and pathological mechanisms leading to the birth of a small vulnerable newborn[J]. Lancet, 2023, 401(10389): 1720-1732. doi: 10.1016/S0140-6736(23)00573-1 pmid: 37167990
[5]	Hofmeyr GJ, Black RE, Rogozińska E, et al. Evidence-based antenatal interventions to reduce the incidence of small vulnerable newborns and their associated poor outcomes[J]. Lancet, 2023, 401(10389): 1733-1744. doi: 10.1016/S0140-6736(23)00355-0 pmid: 37167988
[6]	蒋昊天, 陈超. 不同胎龄早产儿的生存状况及其变化趋势[J]. 中华围产医学杂志, 2024, 27(10): 865-870.
	Jiang HT, Chen C. Survival status and trends of preterm infants of different gestational ages[J]. Zhonghua Weichan Yixue Zazhi, 2024, 27(10): 865-870.
[7]	Zhang YJ, Zhu Y, Zhu L, et al. Prevalence of preterm birth and risk factors associated with it at different gestational ages: a multicenter retrospective survey in China[J]. Saudi Med J, 2022, 43(6): 599-609.
[8]	Zhang YJ, Shen J, Lin SB, et al. The risk factors of preterm birth: A multicentre case-control survey in China in 2018[J]. J Paediatr Child Health, 2022, 58(8): 1396-1406.
[9]	中华医学会围产医学分会胎儿医学学组, 中华医学会妇产科学分会产科学组. 胎儿生长受限专家共识(2019版)[J]. 中华围产医学杂志, 2019, 22(6): 361-380.
	Fetal Medicine Subgroup, Society of Perinatal Medicine, Chinese Medical Association, Obstetrics Subgroup, Society of Obstetrics and Gynecology, Chinese Medical Association. Expert consensus on fetal growth restriction[J]. Zhonghua Weichan Yixue Zazhi, 2019, 22(6): 361-380.
[10]	王昊, 漆洪波. 全球胎儿生长受限指南:求同存异[J]. 中华围产医学杂志, 2024, 27(9): 710-721.
	Wang H, Qi HB. Global guidelines for fetal growth restriction: seeking common ground while respecting differences[J]. Zhonghua Weichan Yixue Zazhi, 2024, 27(9): 710-721.
[11]	Erchick DJ, Hazel EA, Katz J, et al. Vulnerable newborn types: analysis of subnational, population-based birth cohorts for 541 285 live births in 23 countries, 2000-2021[J]. BJOG, 2023. doi: 10.1111/1471-0528.17510.
[12]	Zhao Y, Jia Z, Wang L, et al. Trends in the incidence of high-risk newborns based on a new conceptual framework-Beijing municipality, China, 2013-2022 [J]. China CDC Wkly, 2024, 6(31): 767-771.
[13]	Perlman JM, Ashish KC. Small and vulnerable newborns the major driver of6unacceptable high neonatal mortality in low resource settings[J]. Acta Paediatrica, 2024, 113: 2406-2407.
[14]	Hazel EA, Erchick DJ, Katz J, et al. Neonatal mortality risk of vulnerable newborns: a descriptive analysis of subnational, population-based birth cohorts for 238 203 live births in low- and middle-income settings from 2000 to 2017[J]. BJOG, 2023. doi: 10.1111/1471-0528.17518.
[15]	Suárez-Idueta L, Blencowe H, Okwaraji YB, et al. Neonatal mortality risk for vulnerable newborn types in 15 countries using 125.5million nationwide birth outcome records, 2000-2020[J]. BJOG, 2023. doi: 10.1111/1471-0528.17506.
[16]	Zhu Z, Yuan L, Wang J, et al. Mortality and Morbidity of infants born extremely preterm at tertiary medical centers in China from 2010 to 2019[J]. JAMA Netw Open, 2021, 4(5): e219382.
[17]	Zhu Z, He Y, Yuan L, et al. Trends in bronchopulmonary dysplasia and respiratory support among extremely preterm infants in China over a decade[J]. Pediatr Pulmonol, 2024, 59(2): 399-407.
[18]	Lapehn S, Paquette AG. The Placental epigenome as a molecular link between prenatal exposures and fetal health outcomes through the DOHaD hypothesis[J]. Curr Environ Health Rep, 2022, 9(3): 490-501. doi: 10.1007/s40572-022-00354-8 pmid: 35488174
[19]	Andonotopo W, Bachnas MA, Akbar MIA, et al. Fetal origins of adult disease: transforming prenatal care by integrating Barker's Hypothesis with AI-driven 4D ultrasound[J]. J Perinat Med, 2025, 53(4): 418-438.
[20]	Huicho L, Vidal-Cardenas E, Haapaniemi T, et al. Small vulnerable newborns: the urgent need of strong actions in Peru and the entire Latin America[J]. Lancet Reg Health Am, 2024, 34: 100748.
[21]	Malik H, Yazdani N, Kumari S, et al. Mapping neonatal vulnerability using the Small Vulnerable Newborn (SVN) framework-secondary analysis of PRISMA Pakistan study[J]. Lancet Reg Health Southeast Asia, 2025, 33: 100535.
[22]	Rocha AS, de Cassia Ribeiro-Silva R, Silva JFM, et al. Postnatal growth in small vulnerable newborns: a longitudinal study of 2 million Brazilians using routine register-based linked data[J]. Am J Clin Nutrition, 2024, 119: 444-455.
[23]	Jiang L, Him RL, Sihota D, et al. Supportive care for common conditions in small vulnerable newborns and term infants: the evidence[J]. Neonatology, 2025, 122(suppl 1): 129-151.
[24]	Wang D, Liu E, Perumal N, et al. The effects of prenatal multiple micronutrient supplementation and small-quantity lipid-based nutrient supplementation on small vulnerable newborn types in low-income and middle-income countries: a meta-analysis of individual participant data[J]. Lancet Glob Health, 2025, 13: e298-e308.